Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/9339
Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica
Royo-Bordonada, Miguel Angel ISCIII | Armario, Pedro | Lobos Bejarano, José María | Pedro-Botet, Juan | Villar Alvarez, Fernando ISCIII | Elosua, Roberto | Brotons Cuixart, Carlos | Cortés, Olga | Serrano, Benilde | Camafort Babkowski, Miguel | Gil Núñez, Antonio | Pérez, Antonio | Maiques, Antonio | de Santiago Nocito, Ana | de Castro, Almudena | Alegría, Eduardo | Baeza, Ciro | Yuste-Herranz, Maria Eloisa ISCIII | Sans, Susana | Campos, Pilar
Gac Sanit. 2017 May - Jun;31(3):255-268.
The VI European Guidelines for Cardiovascular Prevention recommend combining population and high-risk strategies with lifestyle changes as a cornerstone of prevention, and propose the SCORE function to quantify cardiovascular risk. The guidelines highlight disease specific interventions, and conditions as women, young people and ethnic minorities. Screening for subclinical atherosclerosis with noninvasive imaging techniques is not recommended. The guidelines distinguish four risk levels (very high, high, moderate and low) with therapeutic objectives for lipid control according to risk. Diabetes mellitus confers a high risk, except for subjects with type 2 diabetes with less than <10 years of evolution, without other risk factors or complications, or type 1 diabetes of short evolution without complications. The decision to start pharmacological treatment of arterial hypertension will depend on the blood pressure level and the cardiovascular risk, taking into account the lesion of target organs. The guidelines don't recommend antiplatelet drugs in primary prevention because of the increased bleeding risk. The low adherence to the medication requires simplified therapeutic regimes and to identify and combat its causes. The guidelines highlight the responsibility of health professionals to take an active role in advocating evidence-based interventions at the population level, and propose effective interventions, at individual and population level, to promote a healthy diet, the practice of physical activity, the cessation of smoking and the protection against alcohol abuse.
Alcohol drinking | Cardiovascular diseases | Cholesterol | Colesterol | Consumo de alcohol | Diabetes mellitus | Enfermedades cardiovasculares | Grasas trans | Guías de práctica clínica | Hipertensión arterial | Hypertension | Practice Guidelines [Publication Type] | Prevención y control | Prevention and control | Tabaco | Tobacco | Trans fatty acids
Age Factors | Biomarkers | Cardiovascular Diseases | Europe | Female | Health Promotion | Humans | Male | Mass Screening | Patient Compliance | Physician's Role | Risk Factors | Spain | Life Style | Practice Guidelines as Topic | Risk Assessment
Files in this item